Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The potential impact of COVID-19-related disruption on tuberculosis burden
Christopher Finn McQuaid, Nicky McCreesh, Jonathan M. Read, et al.
European Respiratory Journal (2020) Vol. 56, Iss. 2, pp. 2001718-2001718
Open Access | Times Cited: 215

Showing 1-25 of 215 citing articles:

COVID-19 and resilience of healthcare systems in ten countries
Catherine Arsenault, Anna Gage, Min Kyung Kim, et al.
Nature Medicine (2022) Vol. 28, Iss. 6, pp. 1314-1324
Open Access | Times Cited: 433
Anti-tuberculosis treatment strategies and drug development: challenges and priorities
Véronique Dartois, Eric J. Rubin
Nature Reviews Microbiology (2022) Vol. 20, Iss. 11, pp. 685-701
Open Access | Times Cited: 316
The potential impact of the COVID-19 pandemic on the tuberculosis epidemic a modelling analysis
Lucia Cilloni, Han Fu, Juan F. Vesga, et al.
EClinicalMedicine (2020) Vol. 28, pp. 100603-100603
Open Access | Times Cited: 286
The impact of COVID-19 on TB: a review of the data
Christopher Finn McQuaid, Anna Vassall, Ted Cohen, et al.
The International Journal of Tuberculosis and Lung Disease (2021) Vol. 25, Iss. 6, pp. 436-446
Open Access | Times Cited: 245
The intersecting pandemics of tuberculosis and COVID-19: population-level and patient-level impact, clinical presentation, and corrective interventions
Keertan Dheda, Tahlia Perumal, Harry Moultrie, et al.
The Lancet Respiratory Medicine (2022) Vol. 10, Iss. 6, pp. 603-622
Open Access | Times Cited: 194
Previous and active tuberculosis increases risk of death and prolongs recovery in patients with COVID-19
Karla Therese L. Sy, Nel Jason Haw, Jhanna Uy
Infectious Diseases (2020) Vol. 52, Iss. 12, pp. 902-907
Open Access | Times Cited: 150
Tuberculosis and COVID-19 co-infection: description of the global cohort

European Respiratory Journal (2021) Vol. 59, Iss. 3, pp. 2102538-2102538
Open Access | Times Cited: 126
The Economics of the COVID-19 Pandemic in Poor Countries
Edward Miguel, Ahmed Mushfiq Mobarak
Annual Review of Economics (2022) Vol. 14, Iss. 1, pp. 253-285
Open Access | Times Cited: 79
COVID-19 and tuberculosis: the double whammy of respiratory pathogens
Mohd Shariq, Javaid Ahmad Sheikh, Neha Quadir, et al.
European Respiratory Review (2022) Vol. 31, Iss. 164, pp. 210264-210264
Open Access | Times Cited: 71
Global, regional, and national age-specific progress towards the 2020 milestones of the WHO End TB Strategy: a systematic analysis for the Global Burden of Disease Study 2021
Jorge R Ledesma, Jianing Ma, Meixin Zhang, et al.
The Lancet Infectious Diseases (2024) Vol. 24, Iss. 7, pp. 698-725
Open Access | Times Cited: 28
Pathology of TB/COVID-19 Co-Infection: The phantom menace
Gabriel Tassi Mousquer, Alessandra Peres, Marilu Fiegenbaum
Tuberculosis (2020) Vol. 126, pp. 102020-102020
Open Access | Times Cited: 106
The impact of the COVID-19 epidemic on tuberculosis control in China
Fei Huang, Xia Yin-yin, Hui Chen, et al.
The Lancet Regional Health - Western Pacific (2020) Vol. 3, pp. 100032-100032
Open Access | Times Cited: 101
Impact of COVID-19 pandemic on chronic diseases care follow-up and current perspectives in low resource settings: a narrative review.
Ginenus Fekadu, Firomsa Bekele, Tadesse Tolossa, et al.
International Journal of Physiology Pathophysiology and Pharmacology (2021) Vol. 13, Iss. 3, pp. 86-93
Closed Access | Times Cited: 95
Increase in Tuberculosis Diagnostic Delay during First Wave of the COVID-19 Pandemic: Data from an Italian Infectious Disease Referral Hospital
Francesco Di Gennaro, Gina Gualano, Laura Timelli, et al.
Antibiotics (2021) Vol. 10, Iss. 3, pp. 272-272
Open Access | Times Cited: 81
Mitigating the impact of COVID-19 on tuberculosis and HIV services: A cross-sectional survey of 669 health professionals in 64 low and middle-income countries
Mishal Khan, Sonia Rego, Joaquín Benítez Rajal, et al.
PLoS ONE (2021) Vol. 16, Iss. 2, pp. e0244936-e0244936
Open Access | Times Cited: 75
Tuberculosis related disability: a systematic review and meta-analysis
Kefyalew Addis Alene, Kinley Wangdi, Samantha Colquhoun, et al.
BMC Medicine (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 71
Diagnostic biomarkers for active tuberculosis: progress and challenges
Betânia M. F. Nogueira, Sonya Krishnan, Beatriz Barreto‐Duarte, et al.
EMBO Molecular Medicine (2022) Vol. 14, Iss. 12
Open Access | Times Cited: 54
The COVID-19 and TB syndemic: the way forward
Anete Trajman, Irina Felker, Layana Costa Alves, et al.
The International Journal of Tuberculosis and Lung Disease (2022) Vol. 26, Iss. 8, pp. 710-719
Open Access | Times Cited: 53
Tuberculosis caused by Mycobacterium africanum: Knowns and unknowns
Marta Silva, Baltazar Cá, Nuno S. Osório, et al.
PLoS Pathogens (2022) Vol. 18, Iss. 5, pp. e1010490-e1010490
Open Access | Times Cited: 39
Prevalence of covid-19 among patients with chronic obstructive pulmonary disease and tuberculosis
Muhammad Muneeb Hassan, Muhammad Ameeq, Farrukh Jamal, et al.
Annals of Medicine (2023) Vol. 55, Iss. 1, pp. 285-291
Open Access | Times Cited: 31
Scientific advances and the end of tuberculosis: a report from the Lancet Commission on Tuberculosis
Michael Reid, Yvan Jean Patrick Agbassi, Nimalan Arinaminpathy, et al.
The Lancet (2023) Vol. 402, Iss. 10411, pp. 1473-1498
Closed Access | Times Cited: 30
Risk factors identification of COVID‐19 patients with chronic obstructive pulmonary disease: A retrospective study in Punjab‐Pakistan
Muhammad Muneeb Hassan, M. H. Tahir, Muhammad Ameeq, et al.
Immunity Inflammation and Disease (2023) Vol. 11, Iss. 8
Open Access | Times Cited: 25
Impact of COVID-19 pandemic and anti-pandemic measures on tuberculosis, viral hepatitis, HIV/AIDS and malaria–A systematic review
Barbora Kessel, Torben Heinsohn, Jördis J. Ott, et al.
PLOS Global Public Health (2023) Vol. 3, Iss. 5, pp. e0001018-e0001018
Open Access | Times Cited: 22
Impact of the COVID-19 pandemic on tuberculosis laboratory services in Europe
Vladyslav Nikolayevskyy, Yen Holicka, Dick van Soolingen, et al.
European Respiratory Journal (2020) Vol. 57, Iss. 1, pp. 2003890-2003890
Open Access | Times Cited: 57
Insight into impact of COVID-19 epidemic on tuberculosis burden in China
Hongguang Chen, Konglai Zhang
European Respiratory Journal (2020) Vol. 56, Iss. 3, pp. 2002710-2002710
Open Access | Times Cited: 51
Page 1 - Next Page

Scroll to top